Dimed S.A. Distribuidora de Medicamentos (PNVL3) — Net Asset Quality Index
Dimed S.A. Distribuidora de Medicamentos (PNVL3) has a Net Asset Quality Index of 35.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of R$3.66 Billion minus total liabilities of R$2.36 Billion yields net assets of R$1.30 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Dimed S.A. Distribuidora de Medicamentos for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Dimed S.A. Distribuidora de Medicamentos Net Asset Quality Index Over Time (2000–2025)
This chart shows how Dimed S.A. Distribuidora de Medicamentos's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of March 2026, the index stands at 35.5%, representing net assets of R$1.30 Billion against total assets of R$3.66 Billion BRL. For live market cap and overall valuation, see Dimed S.A. Distribuidora de Medicamentos market cap and net worth.
Annual Net Asset Quality Index for Dimed S.A. Distribuidora de Medicamentos (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for Dimed S.A. Distribuidora de Medicamentos from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is Dimed S.A. Distribuidora de Medicamentos's equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (BRL) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 33.5% | R$1.28 Billion | R$3.83 Billion | R$2.55 Billion | ▼ -3.1 pp |
| 2024 | 36.6% | R$1.23 Billion | R$3.38 Billion | R$2.14 Billion | ▼ -1.6 pp |
| 2023 | 38.1% | R$1.17 Billion | R$3.08 Billion | R$1.90 Billion | ▼ -2.4 pp |
| 2022 | 40.5% | R$1.11 Billion | R$2.73 Billion | R$1.62 Billion | ▼ -3.4 pp |
| 2021 | 43.9% | R$1.05 Billion | R$2.38 Billion | R$1.33 Billion | ▼ -2.1 pp |
| 2020 | 46.1% | R$1.01 Billion | R$2.19 Billion | R$1.18 Billion | ▲ +10.2 pp |
| 2019 | 35.9% | R$524.18 Million | R$1.46 Billion | R$936.11 Million | ▼ -10.5 pp |
| 2018 | 46.4% | R$463.91 Million | R$1.00 Billion | R$536.46 Million | ▲ +1.5 pp |
| 2017 | 44.9% | R$426.75 Million | R$950.17 Million | R$523.42 Million | ▼ -1.6 pp |
| 2016 | 46.5% | R$381.65 Million | R$820.97 Million | R$439.32 Million | ▲ +1.2 pp |
| 2015 | 45.3% | R$344.14 Million | R$759.97 Million | R$415.82 Million | ▲ +2.0 pp |
| 2014 | 43.3% | R$311.30 Million | R$719.27 Million | R$407.97 Million | ▼ -2.9 pp |
| 2013 | 46.2% | R$276.90 Million | R$599.89 Million | R$323.00 Million | ▼ -0.5 pp |
| 2012 | 46.7% | R$233.64 Million | R$500.82 Million | R$267.18 Million | ▲ +1.6 pp |
| 2011 | 45.1% | R$199.24 Million | R$442.15 Million | R$242.91 Million | ▼ -0.8 pp |
| 2010 | 45.9% | R$173.03 Million | R$377.11 Million | R$204.07 Million | ▲ +0.3 pp |
| 2009 | 45.6% | R$151.86 Million | R$333.08 Million | R$181.22 Million | ▼ -1.8 pp |
| 2008 | 47.4% | R$130.81 Million | R$275.75 Million | R$144.94 Million | ▼ -2.0 pp |
| 2007 | 49.5% | R$125.39 Million | R$253.46 Million | R$128.07 Million | ▼ -0.8 pp |
| 2006 | 50.3% | R$117.74 Million | R$234.29 Million | R$116.55 Million | ▲ +0.5 pp |
| 2005 | 49.7% | R$108.19 Million | R$217.51 Million | R$109.32 Million | ▼ -5.9 pp |
| 2004 | 55.7% | R$100.20 Million | R$179.97 Million | R$79.77 Million | ▲ +1.2 pp |
| 2003 | 54.4% | R$93.62 Million | R$172.02 Million | R$78.40 Million | ▼ -6.5 pp |
| 2002 | 60.9% | R$88.44 Million | R$145.21 Million | R$56.77 Million | ▲ +6.2 pp |
| 2001 | 54.7% | R$85.61 Million | R$156.51 Million | R$70.89 Million | ▼ -0.7 pp |
| 2000 | 55.4% | R$81.94 Million | R$147.79 Million | R$65.85 Million | — |